Skip to content

Correlation of Serum Lactate and Activity of Multiple Sclerosis

Correlation of Serum Lactate and Activity of Multiple Sclerosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04210960
Enrollment
80
Registered
2019-12-26
Start date
2019-12-23
Completion date
2020-06-01
Last updated
2019-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple sclerosis, serum lactate and MRS

Brief summary

Correlation of serum lactate and activity of multiple sclerosis and its correlation to different type of MS

Detailed description

Correlation of serum lactate and activity of multiple sclerosis and its correlation to different type of MS and magentic resonanace imaging , magentic resonanace spectroscopy

Interventions

RADIATIONMagentic resonanace imaging

The brain MR imaging examinations were done by using a 3 tesla scanner (Acheiva; Philips Medical Systems, Best, Netherlands). All patients were examined in the supine position using head coil. Routine images (T2, T1, FLAIR) and double inversion recovery sequence (DIR) were done to all patients: repetition time (TR) \_ 9583 sec, echo time (TE) \_ 25 sec, inversion time (TI) \_ 3400 sec, IR delay \_ 325 sec, echo train length (ETL) \_ 17, 50 contiguous axial slices, thickness \_ 3 mm, matrix size 240× 142 mm2, field of view (FOV) 230× 184 mm2.

RADIATIONMagentic resonanace spectroscopy

Magnetic Resonance (MR) spectroscopy is a noninvasive diagnostic test for measuring biochemical changes in the brain.While magnetic resonance imaging (MRI) identifies the anatomical location of a lesion, MR spectroscopy compares the chemical composition of normal brain tissue with abnormal brain tissue. This test can also be used to detect tissue changes in stroke and epilepsy.

Sponsors

Mansoura University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

-Patients with multiple sclerosis (RRMS,PPMS and SPMS)

Exclusion criteria

-Patients with any other medical conditions that may affect the serum lactate level

Design outcomes

Primary

MeasureTime frameDescription
Biochemical testing2 daysPlasma lactate was assayed according to Trinder method14 . All assays were carried out with Bechman Coulter AU480 autoanalyzer (USA).

Countries

Egypt

Contacts

Primary ContactEsmael M Ahmed, MD
deltaneuro@yahoo.com00201000372787

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026